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Mycobacterium avium subsp. paratuberculosis (MAP) is the etiologic agent of Johne’s
Disease in ruminants. This enteritis has significant economic impact and worldwide
distribution. Vaccination is one of the most cost effective infectious disease control
measures. Unfortunately, current vaccines reduce clinical disease and shedding, but are of
limited efficacy and do not provide long-term protective immunity. Several strategies have
been followed to mine the MAP genome for virulence determinants that could be applied
to vaccine and diagnostic assay development. In this study, a comprehensive mutant bank
of 13,536 MAP K-10 Tn5367 mutants (P > 95%) was constructed and screened in vitro for
phenotypes related to virulence. This strategy was designated to maximize identification
of genes important to MAP pathogenesis without relying on studies of other mycobacterial
species that may not translate into similar effects in MAP. This bank was screened for
mutants with colony morphology alterations, susceptibility to D-cycloserine, impairment in
siderophore production or secretion, reduced cell association, and decreased biofilm and
clump formation. Mutants with interesting phenotypes were analyzed by PCR, Southern
blotting and DNA sequencing to determine transposon insertion sites. These insertion
sites mapped upstream from the MAP1152-MAP1156 cluster, internal to either the Mod
operon gene MAP1566 or within the coding sequence of lsr2, and several intergenic
regions. Growth curves in broth cultures, invasion assays and kinetics of survival and
replication in primary bovine macrophages were also determined. The ability of vectors
carrying Tn5370 to generate stable MAP mutants was also investigated.
Keywords: Johne’s Disease, Mycobacterium paratuberculosis, transposon, mutant bank, bovine macrophages
INTRODUCTION
Mycobacterium avium subsp. paratuberculosis (MAP) is the eti-
ologic agent of Johne’s Disease (JD) in ruminants. This enteri-
tis has significant economic impact and worldwide distribution
(Sweeney, 1996). In the United States, annual losses to the dairy
industry have been estimated from 250 million (Ott et al., 1999)
to $1.5 billion (Stabel, 1998). Vaccination is one of the most cost
effective disease control measures. Unfortunately, though there
are JD vaccines that reduce clinical disease and shedding, their
efficacies are limited and none afford long-term protective immu-
nity. For example in the United States, Mycopar® (Boehringer
Abbreviations: CAS, Chrome azurol S; CFU, Colony forming units; DCS, D-
cycloserine; Hyg, Hygromycin; JD, Johne’s Disease; Kan, Kanamycin; MAP,
Mycobacterium avium subsp. paratuberculosis; MDM, Monocyte-derived
macrophage; MOADC, Middlebrook 7H9 broth enriched with oleic acid albumin
dextrose complex; Msmeg, Mycobacterium smegmatis; MTB, Mycobacterium
tuberculosis; OD, Optical density; ORF, Open reading frame; PBS, Phosphate
buffered saline; SEM, Standard error of the mean.
Ingelheim Vetmedica, Inc.) is the only licensed vaccine against
JD. However, this vaccine is derived from M. avium Strain 18
(Bastida and Juste, 2011), and therefore does not have an optimal
antigenic repertoire. Another bacterin, Silirum® (Zoetis Animal
Health) is being tested in Australia and approved for limited
use. It is a heat-killed MAP vaccine strain with improved safety.
This formulation may possess a better antigenic repertoire but
heat-killing may reduce efficacy. Neoparasec® (Rhone-Merieux)
contains the live-attenuated MAP strain 316F while Gudair®
(Zoetis Animal Health) is heat-killed 316F and licensed for use
in sheep and goats. However, current vaccines cannot distin-
guish vaccinated from infected animals, thus compromising JD
diagnostic tests (Hines et al., 2014), and strain 316F was gen-
erated in the 1920’s by random attenuation procedures (e.g.,
passages on ox bile) and their attenuating mutations are only now
being investigated (Bull et al., 2013). In last analysis, a vaccine of
high efficacy is needed for an effective control of JD (Lu et al.,
2013).
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The MAP wild type strain K-10 genome has been sequenced,
annotated and reannotated by optical mapping (Li et al., 2005;
Wu et al., 2009). The updated K-10 genome is represented by a
circular map of 4,829,781 bp encoding 4350 open reading frames
(ORFs) with 69.3% GC content. In this genome, about 60%
of the ORFs have known homologs in databases but only 30%
have definitive function predictions (Bannantine et al., 2012).
Several strategies have been followed to mine the MAP genome
for virulence determinants or antigens of diagnostic importance
(Bannantine and Paustian, 2006; Cho et al., 2007; Li et al., 2007).
One approach relied on identifying MAP genes with known
M. tuberculosis (MTB) homologs or orthologs (Sampson et al.,
2004; Bach et al., 2006). For example, based on the attenuation
of MTB leuD mutants (Sampson et al., 2004), the corresponding
MAP leuD mutants were constructed by allelic exchange, char-
acterized by carbon and nitrogen source utilization, showed to
be attenuated in mice (Chen et al., 2012a,b), and provide pro-
tection against wild type challenge in goats (Faisal et al., 2013).
Indeed, differences in gene organization may lead to context-
dependent function: e.g., even homologous genes in MAP and
M. avium subsp. hominissuis (MAH) may play different roles in
pathogenesis (Wu et al., 2006). In addition, genomic differences
may be associated with specific hosts (Bannantine et al., 2012).
Thus, strategies based on gene homology are not comprehensive.
We have previously demonstrated that transposon Tn5367 inserts
relatively random into the MAP genome (Harris et al., 1999).
Another study generated a mutant bank of 5060 K-10 mutants
(P > 70%) (Shin et al., 2006). Based on bioinformatic analy-
sis, 11 mutants were selected for mouse infection experiments
(Shin et al., 2006), identifying potential virulence genes (gcpE,
pstA, kdpC, papA2, impA, umaA1, and fabG2_2). In this study, we
constructed an expanded and comprehensive bank of 13,536K-10
mutants (P > 95%) and performed phenotypic screens in vitro.
We believe this strategy maximizes possible hits in genes impor-
tant to MAP pathogenesis without relying on studies on other
mycobacterial species that may not always translate into simi-
lar effects in MAP. We also tested the utility of vectors carrying
Tn5370 (McAdam et al., 2002) to generate stable MAP mutants.
MATERIALS AND METHODS
BACTERIAL STRAINS, GROWTH CONDITIONS AND
RECOMBINANT DNA
A virulent clinical isolate of MAP (original stock of strain K-10)
was used throughout the study (Foley-Thomas et al., 1995). MAP
cultures were grown standing with occasional shaking at 37◦C
in complete Middlebrook 7H9 media (MOADC-Plus) as previ-
ously described (Harris et al., 1999); see also Section Transposon
mutagenesis below. Depending on the experiment, the supple-
mentation with mycobactin J (Allied Monitor, Fayette, MO)
varied from 0.5 to 2.0μg/ml. For further characterization of the
selected mutants, we used this media without L-tryptophan and
casamino acids containing vitamins (MOADC). E. coli DH5α
cells, used as cloning hosts, were grown on Luria-Bertani agar
or broth supplemented with 50μg/ml kanamycin (Kan). The
conditionally replicating (temperature sensitive) recombinant
mycobacteriophage phAE94 (Bardarov et al., 1997) was used to
deliver the transposon Tn5367, and signature-tag TM4 phage
derivatives of the thermosensitive vector phAE87 were used to
deliver Tn5370 (Bardarov et al., 1997; Cox et al., 1999; McAdam
et al., 2002). Phage vectors were propagated in M. smegmatis
(Msmeg)mc2155 at 30◦C as described previously (Bardarov et al.,
1997). The Kan-resistance (Kanr) Tn5367 and the hygromycin
(Hyg)-resistant (Hygr) Tn5370 transposons are derived from the
insertion sequence IS1096 from Msmeg (Cirillo et al., 1991).
TRANSPOSON MUTAGENESIS
MAP cultures were grown to ca. 1.5 × 108 colony forming units
(CFU)/ml (OD600 0.38 to 0.75). Cultures (50ml) were con-
centrated by centrifugation and resuspended in 1ml of MP
buffer (50mM Tris-HCl, pH 7.6; 150mM NaCl; 2mM CaCl2).
Bacteria and phage were incubated at the non-permissive temper-
ature (37◦C) and stop buffer was added as described previously
(Bardarov et al., 1997; Harris et al., 1999). The addition of the
stop buffer with sodium citrate helps to prevent further phage
infections that may lead to multiple transposon insertions in a
single strain. Under these conditions, the potential number of
double insertions was shown to be at most 1 in 12 mutants
(8.3%). Kanr or Hygr colonies were selected on MOADC-Plus
medium without Tween plus 15 g/l agar containing 50μg/ml Kan
or 75μg/ml Hyg, supplemented with 0.4% Bacto Casamino Acids
(Difco, Becton Dickinson, Franklin Lakes, NJ), and 40μg/ml L-
tryptophan. Transductants were isolated from these plates after
6–8 week incubation period at 37◦C.
MUTANT SCREENING AND CHARACTERIZATION ASSAYS
Visual screen for colony morphology mutants
To identify colony morphology, MAP mutant strains were grown
individually in 96-well microtiter plates in MOADC-Plus fully-
supplemented media with 0.5μg/ml mycobactin J, as described
above. Plates were photographed and pictures visually inspected
for colony morphology alterations in the bottom of the corre-
sponding wells. Colony morphology alterations were confirmed
by further observations on the corresponding agar plates.
Susceptibility to D-cycloserine
Screen was accomplished by first determining the highest concen-
tration of D-cycloserine (DCS) that would allow wild type growth
to occur onMOADC-Plus fully-supplemented solid media (with-
out Tween) for both MAP wild type K-10 and most randomly
selected transposon mutants. All mutant strains were then indi-
vidually replicated onto solid media without and with DCS at the
established concentration. After 8 week incubation at 37◦C, DCS
susceptibility phenotypes were evaluated and classified as hyper-
susceptible (failed to grow or grew poorly on DCS), wild type
(grew normally, similarly to K-10 on DCS), and resistant (grew
faster than K-10 on DCS, reaching a larger colony size).
Miscellaneous screening procedures
To screen for mutants deficient in siderophore production or
secretion, individual mutant colonies were grown on MOADC-
Plus media, as previously described (Harris et al., 1999). A por-
tion of the bacterial colony was then aseptically transferred onto
modified Chrome azurol S (CAS) plates. This media consisted of
72.9mg/l of hexadecyltrimethylammonium bromide (Sigma, St
Louis, MO), 60.5mg/l of CAS (Sigma), 10ml/l of iron solution
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(1mM FeCl3·6H2O, 10mM HCl), 4.7 g/l of Middlebrook 7H9
broth base (Difco, Becton Dickinson), 2ml/l glycerol and 15 g/l
agar adjusted to pH 5.9. The transferred cell patches were incu-
bated at 37◦C for 2 weeks and visually screened for the absence
of a yellowish halo around the colonies, as previously described
(Schwyn and Neilands, 1987). The presence of a halo indicates
that siderophores produced and secreted by the colony bind ferric
iron in the media.
Biofilm production, thought to be linked to bacterial virulence
was also examined. Bacteria were grown in MOADC-Plus broth
using plastic tubes and for several weeks. The presence of biofilm
was established by visual observation at the sides of the tubes and
at the liquid-air interphase. Additional miscellaneous screens are
described in the Supplementary Material.
Mutant characterization in BoMac cells
BoMac (Stabel and Stabel, 1995) monolayers adherent to glass
coverslips were infected with approximately the same inoculum
(MOI 10:1) in RPMI standard tissue culture medium supple-
mented with 2% fetal bovine serum for 2–3 h (invasion incuba-
tion) at 39◦C. Cells were washed, coverslips removed, fixed and
acid-fast stained. For each experimental group, a minimum of
at least 100 cells were examined at 1000X magnification under
a microscope to determine the percentage of macrophages con-
taining acid-fast bacilli and to enumerate the number of bacteria
per macrophage. Bacterial growth at various times post-infection
(e.g., Day 0 after invasion incubation and Day 4) was determined
by colony counts and BACTEC radiometric assays. Monolayers
were lysed with 0.05% sodium dodecyl sulfate for 30min, and
lysates were inoculated into BACTEC 12B vials containing 14C-
palmitate supplemented with 2.0μg/ml of mycobactin J and 1ml
of egg yolk. The BACTEC 460 instrument (Becton Dickinson
Diagnostic Instrument Systems, Sparks, MD) was utilized to
determine the release of 14CO2 from palmitate that was recorded
by the instrument as a growth index (recorded every 24 h until the
cumulative index reached 2000 in about 20 days). These indices
were converted into viable cell numbers per well (CFUs) using a
previously described formula (Lambrecht et al., 1988). The full
validation of this method is given elsewhere (Zhao et al., 1997,
1999). As needed, results were confirmed by CFU determinations
on MOADC-Plus agar with 2.0μg/ml mycobactin J.
OLIGONUCLEOTIDE PRIMERS AND PCR
The oligonucleotide primers used in this study are listed in
Table 1. The general conditions for the PCR reactions were:
0.03ml reaction mixture volume containing 170 nM of each spe-
cific primer pair, in the presence of 1× NH4-based Reaction
Buffer (Bioline USA, Inc., Taunton, MA), 1.7mM MgCl2, 8.3%
(v/v) DMSO, 0.25mM deoxynucleoside triphosphates and 1.5
units of Biolase™ DNA Polymerase (Bioline USA, Inc.). Thermo
cycler settings of 95◦C for 5min, followed by 30 cycles of 95◦C for
30 s, 61◦C for 45 s, 72◦C for 1min and a final extension at 72◦C
for 7min.
SOUTHERN BLOTTING
Chromosomal DNA was isolated from wild type and mutant
stains. To determine the presence of a transposon insertion,
Table 1 | List of primers used in this study.
Primer Sequence (5′–3′)
2E11-IP-F GCTGCAGCAACCAGCCGA
2E11-IP-R CCACCGTCACCGCAGGTAGA
3H4-F TCGCGGTCCTCGTATTCGCT
3H4-R TGTCGGACGTGTCCGGTCAC
4H2-F TCAAGTGGGTTGTGCCCCGT
4H2-R GCTACCCAGGAGACGCGCCT
22F4-F GTATCGACCGGTTGTTGATG
22F4-R GCCGATGTAGTTGTGGTTGA
40A9-IP1-F GGATGAATCCTCGGCCTTGG
40A9-IP1-R CCGACGGCGTAGTCTGCAAT
AMT32 CTCTTGCTCTTCCGCTTCTTCTCC
AMT152 TTGCTCTTCCGCTTCTTCT
Hygro-F ATAGACGTCGGTGAAGTCGACGAT
Hygro-R GAATCCCTGTTACTTCTCGACCGT
IS900-F GGATGGCCGAAGGAGATTGG
IS900-R GCAGCTCGACTGCGATGTCA
IS1096-F TCGCACTTGACGGTGTA
IS1096-R GTCGGCTCATCGAACAT
Kan-F TCGAGGCCGCGATTAAATTCCACC
Kan-R ATTCATTCGTGATTGCGCCTGAGC
MAP1566-F GCTCTAGAGCTGGCATCAGGGCACTCAAGAAA
MAP1566-R CCCAAGCTTGGGTATTCGCTGCACAGCATGTCAGGT
RS6-4 GTAATACGACTCACTATAGGGCNNNNCATG
SP1 TGCAGCAACGCCAGGTCCACACT
SP2 CTCTTGCTCTTCCGCTTCTTCTCC
STM5370-1 TGCTAGGCGTCGGCCATTAGC
T7 TAATACGACTCACTATAGGG
for mutants derived from Tn5367, DNA samples were digested
with EcoRI, which does not cut within this transposon. For
Tn5370 derivatives, DNA samples were digested with NheI
and NdeI, which do not cut within this transposon. Digested
DNA fragments from both wild type and mutant strains were
electrophoresed on a standard agarose gel and transferred to
a nylon membrane (Osmonics, Inc., GE Water and Process
Technologies, Trevose, PA). Probes were prepared by PCR-
amplification using specific primers (Table 1): IS1096 probe
was amplified from Msmeg genomic DNA with IS1096-F and
IS1096-R and IS900 probe was amplified from MAP genomic
DNA using IS900-F and IS900-R. The Kan-resistant aph gene
probe for Tn5367 was amplified from pMV262 (Connell et al.,
1993), or plasmids derived there from, with Kan-F and Kan-
R. The Hyg-resistant hyg gene probe for Tn5370 was amplified
from pYUB854 (Bardarov et al., 2002), or plasmids derived
there from, using Hygro-F and Hygro-R. Probes were labeled
with α-[32P]-dCTP (3000Ci/mmol) using the Rediprime DNA
Labeling System (Amersham-Pharmacia Biotech, Inc., Molecular
Dynamics Div., Piscataway, NJ) as described by the manufac-
turer. Hybridization and detection were done as described pre-
viously with minor modifications (Feng et al., 2002). Southern
blot images were digitally captured and processed only to
enhance brightness and contrast (Bio-Rad Imaging system,
Hercules, CA).
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SEQUENCING OF THE TRANSPOSON-INSERTION SITE
In order to locate the transposon insertion sites in the K-
10 genome, DNA was amplified for sequencing analysis by a
nested PCR as previously described (McAdam et al., 2002). A
new primer designated STM5370-1, common to both trans-
posons, was used in place of the original SP1 primer due to
differences in the Tn5367 and Tn5370 transposon sequences.
This primer was designed based on sequence information of
Tn5370 provided Dr. Jeffrey Cirillo (Texas A&M Health Science
Center) that was further supplemented by our own sequenc-
ing studies. The first PCR used the following primers: RS6-4
(degenerate) and STM5370-1. The variable size PCR products
(1μl) from the first cycle were used in a second PCR cycle
with primers T7 and SP2 that are internal to the first cycle
PCR product. These final PCR products were purified by Wizard
PCR Preps DNA Purification System (Promega, Madison, WI).
The samples were run on 1.5% agarose gel electrophoresis to
recover the most concentrated DNA bands and purified by the
GeneClean® III Kit (Qbiogene, MP Biomedicals, LLC, Solon,
OH). DNA samples were sent to The University of Nebraska
Genomics Core Research Facility for sequencing, using AMT152
as primer (Shin et al., 2006). Sample runs were performed on
a Beckman-Coulter CEQ8000 or CEQ2000XL 8-capillary DNA
sequencer using dye-terminator chemistry to provide 500–650 bp
of sequence.
GROWTH CURVES IN BROTH CULTURES
MAP strains were grown to late exponential phase (OD600
between 1.0 and 1.5) at 37◦C from glycerol stocks in MOADC
media (1.0μg/ml mycobactin J), appropriately supplemented
with antibiotics as needed. Applicable culture volumes were inoc-
ulated into 45ml ofMOADCmedia in T75 flasks with vented caps
so that the initial OD600 was approximately 0.05. Each culture was
incubated at 37◦C standing with OD600 readings being taken on
days 0, 3, 5, 7, 10, 12, 14, 17, 21, 24, and 28 around the same time
each day. CFU counts were also determined on MOADC agar.
PRIMARY BOVINE MACROPHAGE ASSAY
Monocyte-derived macrophages (MDMs) from a JD negative
dairy cow were elutriated and enriched as described (Lamont
and Sreevatsan, 2010). Incubations were conducted in a 37◦C
humidified chamber containing 5% CO2. Approximately 2.0 ×
107 MDMs were seeded into separate T25 flasks and allowed
to adhere for 2 h. MDMs were washed thrice to remove non-
adherent cells and fresh RPMI 1640 supplemented with 2%
autologous serumwas added prior toMAP infection. Subcultured
MAP (K-10 wild type or mutant strains) were grown to an OD600
of 0.5 (approximately 1.0 × 108 cells/ml) and pelleted at 8000× g
for 10min. The pellet was washed thrice using 1X phosphate
buffered saline (PBS), resuspended in RPMI 1640 containing 2%
autologous serum (MOI 10:1), and vortexed for 5min. MAP
cells were repeatedly drawn through a 21-gage needle to break
bacterial clumps. Cells were incubated at 37◦C for 5min to sed-
iment any remaining clumps and only the upper 2/3rd volume
was used for infection. MDMs were infected with MAP for 2 h
(invasion incubation), washed thrice with 1X PBS to remove non-
adherent bacteria, and recovered in RPMI 1640 supplemented
with 2% autologous serum for the following post-infection time
points: 0, 2, 6, 12, 24, and 48 h after the completion of the inva-
sion incubation period. Upon completion of each post-infection
time point, MDMs were washed thrice in 1X PBS and incubated
with 0.01% Triton X-100 in PBS for 5min at room tempera-
ture. The lysate was subjected to differential centrifugation at
388×g and 8000× g for 5min each to remove MDMs and
pellet bacteria, respectively. MAP pellets were washed thrice in
1X PBS at 8000×g for 5min to remove any remaining deter-
gent, and resuspended in 1.0ml of 1X PBS. All time points were
assayed in triplicate. MAP inoculum and post-infection time
points were separately stained using the Baclight Live/Dead kit
(Invitrogen, Carlsbad, CA) and gated for live cells on a flow
cytometer per manufacturer’s instructions as described (Lamont
and Sreevatsan, 2010).
CALCULATION OF GROWTH PARAMETERS AND STATISTICAL
ANALYSIS
Statistical analyses to determine P-values presented in the text
and figures were performed using the Statistical Analysis System
(SAS) software version 9.1.3, 2004 (SAS Institute) using theMixed
Procedure Subroutine. Post-hoc comparisons were carried out
using Tukey adjusted P-values. For calculations involving ODs
and CFUs, logarithmic transformations were applied.
NUCLEOTIDE SEQUENCE ACCESSION NUMBERS
The DNA sequences of transposons Tn5367 (Cirillo, J. D.,
McAdam, R. A., Weisbrod, T. R., Barletta, R. G. and Jacobs,
W. R. Jr.) and Tn5370 (Cirillo, J. D., Rathnaiah, G., McAdam,
R. A., Weisbrod, T. R., Barletta, R. G. and Jacobs, W. R. Jr.)
have been assigned GenBank accession numbers KM232614 and
KM232615, respectively.
RESULTS
GENERATION AND SCREENING OF A TRANSPOSON MUTANT BANK
To investigate virulence factors of MAP, a transposon mutant
bank of MAP wild type K-10 was constructed. The transposon
Tn5367 carrying a Kan resistance marker (Bardarov et al., 1997)
randomly inserted into the bacterial chromosome by transposi-
tion from a thermosensitive phage delivery vector. Nine indepen-
dent infections (8 with phage and 1 control with no phage) were
carried out to ensure that sibling mutants were minimally rep-
resented. A total of 13,536 Kan-resistant mutants were collected
and stored individually in an indexed collection of 141 96-well
plates stored at −80◦C. Each mutant is identified by the plate
number and the coordinates of the well (a letter for the row and
a number for the column): e.g., mutant 4H2 is stocked in plate
4 and the well that intersects row H and column 2 in a 96-well
microtiter plate. In addition, to facilitate screening procedures,
pools of 96 or 24 mutants were also stocked so they could be
easily referred to individual mutants in the indexed collection.
Assuming random transposition and 4500 target genes with sin-
gle transposon insertions [ln (1 − P) = N× ln(1-1/4500)], this
number of mutants yields a P-value of approximately 95% for
insertions in non-essential genes. The full library or a subset of
strains were subjected to various individual screens to find strains
of interest for studying MAP physiology and pathogenesis, and
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principally to search for attenuated strains that could be used as
first-generation vaccine candidates in animal trials. A set of 123
strains, fairly well distributed through the various plates, were
analyzed to show that the library was composed of strains with
diverse phenotypes (Table S1).
Visual screen for colony morphology mutants
Colony morphology of microorganisms is well known to influ-
ence virulence, drug susceptibility and macrophage survival
(Reddy et al., 1996). To identify colony morphology of MAP
mutants, each of the 13,536 mutant strains was grown on
MOADC-Plus media, visually observed and photographed with
a camera. Using this procedure, eight mutants were found that
exhibited colony morphologies different from the wild type strain
(1F3, 4H2, 16B11, 22F4, 65E9, 69D12, 73D7, and 84D12). In
particular, 4H2 displayed highly irregular colony borders and a
rougher surface appearance as compared to K-10 (Figure 1 and
Figure S1A). In contrast, mutant 22F4 displayed a smooth colony
morphotype (Figure S1C). These two mutant strains were fur-
ther tested in BoMac cells (see Section Miscellaneous screening).
It is noted that visual screens may depend on the media used and
undoubtedly have a degree of subjectivity. Thus, less obvious but
yet relevant differences in colony morphotype may not have been
identified.
Susceptibility to DCS
DCS inhibits peptidoglycan biosynthesis in mycobacteria by
the combined inhibition of D-alanine racemase (Alr) and D-
alanine ligase (Chacon et al., 2002, 2009; Feng and Barletta,
2003; Halouska et al., 2014). Inactivation of the Msmeg alr gene
results in a 500-fold reduction in the ability of Msmeg to survive
within phagocytic cells and also determines a DCS hypersuscepti-
ble phenotype (Chacon et al., 2009). In addition, there are several
potential alterations that can lead to DCS susceptibility or resis-
tance including alterations of surface proteins that may also play
a role in pathogenesis. To test this hypothesis in MAP, the entire
mutant bank was screened for DCS susceptibility. First, it was
determined that 20μg/ml DCS was the maximum concentration
FIGURE 1 | (A,B) Identification of a MAP mutant with altered colony
morphology. MAP strains were grown on fully supplemented
MOADC-Plus medium until colonies were approximately 1mm in diameter
(see scale bar) and photographed at 100X magnification. Colony
morphologies for the wild type strain K-10 (A) and the Tn5367 transposon
mutant 4H2 (B) are displayed.
that had no effect on the growth of K-10 and a subset of ran-
domly picked transposon mutant strains. Using this approach, 98
mutant strains were found hypersusceptible to DCS. Sixty-three
strains did not grow: e.g., colony morphotypes 1F3, 16B1, and
22F4 (Figures S1C,D); and normal colony morphotypes 12G8,
37D1, and 30H9. Thirty-five mutants grew poorly: e.g., normal
colonymorphotypes 3D4 and 23B5, but displayed normal growth
without the drug. However, 15 DCS resistant mutants grew faster,
as evidenced by expanded colony sizes: e.g., colony morpho-
types 4H2 (Figures S1A,B), 65E9 and 69D12; and normal colony
morphotype 40A9. The colony morphotypes 4H2 and 22F4 (see
Section Visual screen for colony morphology mutants), as well
as strains 30H9 and 40A9, were selected for further testing in
BoMac cells (see Section Miscellaneous screening). In contrast,
colony morphology mutants 73D7 and 84D12 displayed wild
type susceptibility. In summary, this screen yielded 113 poten-
tially attenuated strains, the greatest number among the assays
performed.
Miscellaneous screening
Chromogenic screening of the entire mutant bank was per-
formed to identify mutants unable to synthesize and/or secrete
siderophores other than mycobactin. Since MAP is a known aux-
otroph for mycobactin, the goal of this experiment was to test
the hypothesis that mycobacterial mutants unable to synthesize
and/or secrete any other type of siderophore may be attenuated
(Fiss et al., 1994). This method identified mutant 1F3 that grew
significantly slower than K-10 in standard mycobactin J supple-
mented media did not produce a halo on the modified CAS
medium plates (Figure 2). This phenotype suggests an impair-
ment of the synthesis or transport of an alternative siderophore
different from mycobactin. This mutant also displayed colony
morphology alterations (see Section Visual screen for colony
morphology mutants) and DCS hypersusceptibility (see Section
Susceptibility to DCS). As stated in Section Generation and
screening of a transposon mutant bank, the entire mutant bank,
as well as 1F3, was stocked as a 96 well-plate culture. Replicate
plating on MOADC-Plus for the CAS assay was conducted 6
months thereafter with all mutants, except 75, being viable.
However, in a subsequent replication years later, mutant 1F3
grew poorly but in sufficient amounts to conduct a preliminary
goat experiment when sent to collaborators in Israel (Livneh
et al., 2005). Unfortunately, subcultures at both laboratories no
longer grew.
Biofilm screening was also performed with a limited set of
ca. 300 mutants to identify strains deficient in biofilm produc-
tion (Figure S2). We identified mutants 2E11, 4E1, and 4E7 that
were impaired in biofilm production. However, mutant 2E11
biofilm deficiency was due to poor growth in the assay. In con-
trast, mutant 4F3 produced more biofilm than the wild type
strain. Additional screens identified mutants 3D4 and 3B11 with
impaired cell association in BoMac cells (Figure S3), and strain
3D9 and 4E7 displayed impaired clump formation (Figure S4).
All of these seven mutants did not display altered colony mor-
photypes. In addition, all of these mutants, except for 3D4,
had normal DCS susceptibilities. Nonetheless, serendipitously,
mutant 2E11 was selected for further studies as preliminary
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FIGURE 2 | Direct visual screen for MAP mutants unable to produce or
secrete siderophores. Mutants were grown on MOADC-Plus media for
about 8 weeks, transferring a portion of the colony to Chrome azurol S
plates since this media does not allow for growth. Labels for the outermost
colonies are shown for each row and column (according to 96-well plate
nomenclature) to designate individual mutants. Mutants that failed to grow
initially are represented by an “×” and mutants that produced a halo are
controls. A scale bar is provided to estimate halo size (blue to yellow color
change when a strong chelating agent removes iron from the dye) after 2
weeks of incubation at 37◦C. The circled colony without a halo is mutant
1F3 impaired in siderophore production or secretion.
assays with MDMs indicated significant attenuation (see Section
Interaction of wild type and mutant strains with primary bovine
macrophages).
MAP mutant characterization in BoMac cells
The invasion, survival and/or replication of selected MAP strains
were first tested in the BoMac cell line, as these cells provide repro-
ducibility over primary macrophages for the extended period of
time that would be required to test a large number of mutants.
Preliminary assessment of bacillary counts for representative
strains was performed by microscopic examination of acid-fast
stained monolayers on glass coverslips. Results were confirmed by
CFU determination and BACTEC assays that were better suited
for screening assays. Finally, the more promising mutants were
screened in this fashion by BACTEC assays. Representative results
are shown for two sets of independent experiments (Figure 3).
In the first set (Figure 3, left), K-10 was compared with 3H4
(with normal colony morphology, but unable to grow in DCS),
4H2 and 22F4. Results at Day 0 (after invasion incubation)
showed that the invasiveness of 3H4 and 22F4 were similar to
K-10 (P > 0.1), but 4H2 was significantly less invasive than the
wild type strain K-10 (P < 0.01), and also less invasive than 3H4
(P < 0.01) and 22F4 (P < 0.05). Survivability for each strain
was estimated by comparing the CFUs at Day 0 and Day 4:
interaction of K-10 with BoMac cells resulted in decreased sur-
vival but the effect was not statistically significant (P > 0.1),
reduced survivability was more pronounced and approached sig-
nificance for 3H4 (P = 0.055), there was almost no change for
4H2 (P > 0.1), but reduction in CFUs was significant for 22F4
FIGURE 3 | Interaction of MAP wild type K-10 and mutant strains with
the BoMac cell line. Macrophage monolayers were infected with bacteria
at a multiplicity of 10:1, incubated and lysed. Counts were taken at Day 0
(after invasion; stripe bars) and Day 4 (post-infection; solid bars). Bacilli were
enumerated using the BACTEC radiometric assay system by recording
growth indices every 24 h until this cumulative index reached 2000 (usually
20 days). These indices were converted into viable cell numbers per well
(CFUs) using a previously described formula that has been extensively
validated for MAP (Lambrecht et al., 1988; Zhao et al., 1997, 1999). Results
represent means (n = 2) ± standard error of the mean. Statistical
significance for pairwise determinations displayed by a line with tick marks
is denoted with asterisks: ∗P-value < 0.05, ∗∗P-value < 0.01 and
∗∗∗P-value < 0.001.
(P < 0.05). Comparison of the overall macrophage CFUs at Day
4 among all strains indicated that the 3H4 burden was not sig-
nificantly different from K-10 (P > 0.1), while 22F4 showed a
reduced burden but was not significantly different (P = 0.075),
while 4H2 showed significantly less CFUs (P = 0.039).
Results for the second set (Figure 3, right), indicated that 30H9
was less invasive than K-10 (P < 0.001), but showed no signifi-
cant difference (P > 0.1) in survivability from Day 0 to Day 4. In
addition, 30H9 had a significantly lesser CFU burden than K-10
at Day 4 (P < 0.001). Notably, for this set, K-10 displayed a simi-
lar reduction in survivability fromDay 0 to Day 4, but in this case,
on account of more precise measurements and reduced number
of means comparisons, the decrease was statistically significant
(P < 0.05). In a separate assay, mutants 12G8 and 37D1 were also
shown to be attenuated in BoMac cells. Mutant 23B5 displayed
an attenuated phenotype when directly tested in MDMs infection
assays (Table S1).
In summary, 4H2 and 30H9 were less invasive than the wild
type K-10 strain, but had similar intracellular survival as K-10. In
contrast, 22F4 was the only strain that was significantly less able
to survive, by the end point, at Day 4 post-infection. The com-
bined effects of invasion and survival, as indicated by the absolute
CFU burdens as determined by the BACTEC assay, at Day 4, indi-
cated that 4H2 and 30H9 were definitely attenuated in BoMac
cells, predominantly by their reduced invasiveness. Thus, these
two strains, once internalized at lower CFU burdens, persisted
post-infection at approximately constant numbers. In contrast,
22F4 was attenuated because of its reduced survival, but the effect
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was of lesser degree. The normal colony morphotype mutant 3H4
behaved similarly to the wild type strain K-10.
FURTHER CHARACTERIZATION OF TRANSPOSON MUTANTS OF
INTEREST
To further characterize mutants of interest, Southern hybridiza-
tion analyses, and identification of transposon insertion sites by
nested PCR sequencing were performed. Tests to identify spe-
cific transposon mutants in mixed infections were developed.
In addition, these mutants were characterized by determination
of growth curves in broth cultures and their interactions with
primary bovine macrophages.
Southern hybridization
To characterize the molecular events that gave rise to the mutant
strains, Southern hybridizations were performed with various
probes. Hybridization with a probe specific for the common
transposon insertion sequence IS1096 showed unique size bands
for 33 mutant strains (not all positive strains shown in Figure 4;
see Table S1), indicating the presence of a single copy of the
corresponding transposon (Figures 4A–B). These results were
confirmed by hybridization with a probe specific for either the
Kan-resistant aph marker for Tn5367 derivatives, or the Hyg-
resistant hyg marker for Tn5370 derivatives. Both probes yielded
bands in the same gel positions as the IS1096 probe (unpublished
results). To verify that mutant strains were derived from K-10 and
that no major molecular rearrangements have occurred, a probe
specific for IS900 was used. As expected, this analysis showed that
all mutant strains analyzed had the same hybridization banding
pattern as the wild type strain K-10 (Figures 4C–D). As mutants
were directly analyzed from the original stocks (Figure 4A), we
noted that 22F4 did not show a clear hybridization band with
IS1096, andmutant 40A9 showed a very faint band. Upon replica-
tion to make large stocks for further analyses, mutant 22F4 clearly
displayed the corresponding hybridization band, but 40A9 dis-
played no band, indicating the potential loss of the transposon
insertion (Figure 4B). In addition, the original stock of mutant
5E5 did not display a hybridization band.
Transposon insertion site identification by sequencing of nested
PCR amplicons
The genomic regions containing transposon insertions of interest
were amplified by nested PCR and sequenced as described (see
Section Sequencing of the transposon-insertion site). Transposon
insertion sites were identified by performing BLASTN identity
searches of the MAP DNA sequences adjacent to transposon
insertion sites against the K-10 complete genome sequence. In
mutants 22F4, 30H9 and STM68, the transposon inserted within
genes of interest (Figure 5A). In mutant 22F4, the transpo-
son insertion site was mapped internal to MAP0460 (lsr2) and
located 110 bp from the ATG start codon. For mutant 30H9,
transposon insertion sites were mapped as internal to MAP1566.
FIGURE 4 | (A–E) Southern blot analysis of MAP wild type K-10 and
transposon insertion mutants. DNA samples from Tn5367 mutants and
the wild type strain (K-10a) were digested with EcoRI (A,B,E). DNA samples
from the Tn5370 mutant STM68 and the wild type strain (K-10b) were
digested with NheI and NdeI (C,D). DNA samples were run on agarose gels,
transferred to a nylon membrane and hybridized with the IS1096 probe to
verify the presence of the transposon (A–C) and the IS900 probe to confirm
that the mutants were derived from MAP (C,D). (B–E) are hybridization
images generated from the same Southern transfer, while (A) was from an
independent transfer.
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FIGURE 5 | (A,B) Transposon insertion sites of MAP mutants. Solid
line wide arrows represent ORFs and indicate the direction of
transcription. Dotted fill wide arrows exemplify ORFs subjected to a
potential polar effect due to the transposon insertion. The dashed line
wide arrow represents a gene cluster transcribed in the same direction.
Bold thick vertical arrows stand for Tn5367 while the bold thin arrow
symbolizes Tn5370 insertion points. Regular thin arrows point to the
DNA segments indicating distances (bp) between the transposon
insertion point and the start or end of the corresponding ORF. Open
black and solid gray (AMT32) sideway triangles represent primers used
in PCR mutant identifications for mixed infection experiments (see
Figure 6). Right angle bent arrows indicate the direction of transcription
of the drug selection markers (aph in Tn5367 derivatives; hyg in
Tn5370 derivative STM68) in the transposon. Diagram representing
relevant genomic regions for mutants are represented: (A) 22F4, 30H9,
and STM68; and (B) 2E11, 3H4, and 4H2.
Serendipitously, another screen from a signature-tagged mutage-
nesis experiment (ca. 300 mutants) identified a Tn5370 mutant
(STM68) with an insertion in the same gene as in 30H9, but
the insertion in STM68 was mapped toward the 3′-end cod-
ing sequence of MAP1566. STM68 is a stable mutant because
Tn5370 lacks the transposase within the transposed region avoid-
ing the potential for further rearrangements in the mutant strain.
In 30H9, Tn5367 is located 272 bp from the ATG start codon,
while mutant STM68 carries a Tn5370 insertion 51 bp from the
TAA termination codon. Thus, for STM68, the insertion may also
exert a polar effect on MAP1567 located downstream within the
operon. Likewise, though the insertion in 30H9 is well upstream
within theMAP1566 coding sequence, a polar effect onMAP1567
cannot be ruled out.
In mutants 2E11, 3H4, and 4H2, the transposon Tn5367
inserted in the intergenic regions (Figure 5B). For mutant
2E11, Tn5367 inserted 130 bp upstream from FadE5 and 30 bp
upstream from MAP3695. In 3H4, the insertion site was
18 bp upstream from MAP2296c and 182 bp downstream from
MAP2297c. In 4H2, the transposon insertion was 39 bp upstream
from MAP1150c and 320 bp downstream from MAP1151c. In
all these cases, it is hypothesized that the transposon affects
the expression of either or both genes adjacent to the insertion
sites, or other genes in close proximity. Sequencing of the orig-
inal isolate of 40A9 putatively identified a transposon insertion
site in the intergenic region between MAP0282c and MAP0283c.
However, as this insertion point could not be further verified and
7 consecutive nucleotides of primer STM5370-1 matched within
MAP0282c sequence, the possibility of spurious priming could
not be ruled out. Comparison of the full genomic sequence of
40A9 with K-10 may be necessary to identify any sequence change
in this mutant strain. However, this analysis is beyond the scope
of this work.
Polymerase chain reaction for mutant verification
To demonstrate the presence of specific transposon insertion
mutants in mixed infections, such as protection challenge exper-
iments, it was necessary to develop a specific PCR test for each
mutant strain. The test is also confirmatory of the sequencing
studies to rule out any spurious transposon insertion site iden-
tifications. To accomplish this goal, based on the sequencing
results, amplicons were synthesized with primers specific for the
sequences adjacent to the transposon insertion sites (Table 1),
and analyzed on agarose gels (Figure 6). Amplification of wild
type K-10 DNA with primers MAP1566-F (within MAP1566 but
upstream from the insertion point) and MAP1566-R (within the
intergenic region between MAP1566 and MAP1567) resulted in a
DNA fragment of 1179 bp (Lanes 3 and 7); these primers yielded
fragments of 3474 bp (Lane 4) and 4560 bp (Lane 8), respectively
for mutants STM68 and 30H9. These sizes are as expected for the
insertion of Tn5370 (2295 bp) or Tn5367 (3381 bp), respectively.
Likewise, amplification of K-10 (Lane 5) and 2E11 (Lane 6) with
primers 2E11-IP-F (within MAP3695) and 2E11-IP-R (within
FadE5) resulted in a DNA fragment of 1845 bp and 5226 bp,
respectively; thus confirming the predicted insertion of Tn5367
in the FadE5 and MAP3695 intergenic region.
PCR of mutants 3H4, 4H2, and 22F4 with specific primers
(3H4-F, 3H4-R, 4H2-F, 4H2-R, 22F4-F, and 22F4-R, respectively)
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from regions adjacent to the insertion gave the same amplification
product to that of K-10 (unpublished results). However, we were
able to confirm the insertion point using a specific primer for the
adjacent sequences and primer AMT32 specific for both Tn5367
and Tn5370 (McAdam et al., 2002; Shin et al., 2006). In this case,
K-10 gave no amplification products (unpublished results). All of
the mutant strains gave amplification products of the expected
sizes: STM68 (1160 bp, Lane 10), 2E11 (1890 bp, Lane 11), 3H4
(1974 bp, Lane 12), 4H2 (1431 bp, Lane 13), 22F4 (561 bp, Lane
14), and 30H9 (941 bp, Lane 15). We obtained the same amplifi-
cation product for K-10 and 40A9 using primers 40A9-IP1-F and
FIGURE 6 | Analysis of MAP Tn5367 (3,381bp) and Tn5370 (2295bp)
insertion mutants by PCR. Lane 1, Invitrogen TrackIt™ 1Kb Plus DNA
Ladder; Lanes 2 and 9, empty. Amplicons for the DNA template-primer
combinations and corresponding sizes are: Lanes 3 and 7, K-10 with
MAP1566-F and MAP1566-R, 1179 bp; Lane 4, STM68 with MAP1566-F and
MAP1566-R, 3474 bp; Lane 5, K-10 with 2E11-IP-F and 2E11-IP-R, 1845 bp;
Lane 6, 2E11 with 2E11-IP-F and 2E11-IP-R, 5226 bp; Lane 8, 30H9
MAP1566-F and MAP1566-R, 4560 bp; Lane 10, STM68 with MAP1566-F
and AMT32, 1160 bp; Lane 11, 2E11 with 2E11-IP-F and AMT32, 1890 bp;
Lane 12, 3H4 with 3H4-R and AMT32, 1974 bp; Lane 13, 4H2 with 4H2-F
and AMT32, 1431 bp; Lane 14, 22F4 with 22F4-F and AMT32, 561 bp; Lane
15, 30H9 with MAP1566-R and AMT32, 941 bp. Relevant band sizes (bp) for
the DNA ladder are displayed to the left.
40A9-IP1-R adjacent to MAP0283c andMAP0282c (unpublished
results). Thus, results confirmed the location of the transposon
insertion sites obtained by DNA sequencing. Furthermore, the
unique sizes of the PCR amplicons were successfully used to iden-
tify the presence of each mutant strain in animal experiments
(Bannantine et al., 2014; Hines et al., 2014).
Determination of growth curves in broth cultures
As these MAP mutants were developed as first generation can-
didate vaccine strains, it was important to determine if their
corresponding in vitro growth rates in broth cultures were similar
to the wild type K-10 strain. Determination and statistical analysis
of growth curves indicated that both wild type andmutant strains
grew approximately at the same rate in MOADC, as assessed by
OD (Figure 7A) or CFU (Figure 7B) determinations. In partic-
ular for OD values, growth rates of the mutant strains were not
significantly different compared to K-10 (P > 0.05), except for
30H9 that grew slightly faster (P = 0.047). Likewise the more
detailed CFU calculations showed a similar effect, but in this case
3H4 grew faster (P = 0.021), 22F4 had a slower rate (P = 0.019)
and growth of 30H9 did not differ significantly (P > 0.05) from
K-10. These results suggest that the mutations in these strains
are related to properties that relate to virulence such as survival
and replication in BoMac cells rather than standard physiological
traits. This characteristic is desirable for candidate live-attenuated
vaccine strains as the isolates can be readily propagated in broth
cultures to prepare inoculums for vaccine delivery.
Interaction of wild type and mutant strains with primary bovine
macrophages
As macrophages play a key role in MAP infections, to confirm
the results obtained with BoMac cells and characterize addi-
tional mutants, we determined the interaction of wild type and
mutant strains with primary macrophages. MDMs were infected
with each strain at a MOI of 10:1, incubated to allow inva-
sion, washed and lysed immediately or at various time points
post-infection to determine colony counts (Figures 8–10). The
results indicated that strains 2E11 (P < 0.05), 3H4 (P < 0.01)
and 22F4 (P < 0.001) were significantly less invasive than K-10
(Figure 8). No major differences were observed for all four cases
FIGURE 7 | (A,B) Growth curves of MAP wild type K-10 and mutant
strains. Strains were inoculated into MOADC media at an initial optical
density (OD600) of approximately 0.05. Cultures were incubated at 37◦C
standing for 28 days. OD readings (A) and CFU after 5 weeks (B) were taken.
Results represent means (n = 3) ± standard error of the mean. See text for
relevant P-values.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2014 | Volume 4 | Article 144 | 9
Rathnaiah et al. Mycobacterium paratuberculosis mutant bank
FIGURE 8 | Invasion of MAP wild type K-10 and mutant strains in
bovine macrophages. Procedures followed are described in Lamont and
Sreevatsan (2010). MAP uptake at the end of the invasion incubation period
(percent invasion, 2 h after infection). Results represent means
(n = 3) ± standard error of the mean. Statistical significance for pairwise
determinations displayed by a line with tick marks is denoted with
asterisks: ∗P-value < 0.05, ∗∗P-value < 0.01 and ∗∗∗P-value < 0.001.
in comparison to K-10 P > 0.1. These results sharply contrast
with strain invasiveness for BoMac cells (see Section Discussion).
The full short kinetics of the interaction of MAP strains with
MDMs is shown in Figure 9. This analysis demonstrates that for
most strains there is a pronounced killing phase immediately after
invasion incubation up to 6–12 h, followed by a recovery phase
and eventual stabilization of the CFU burdens. This aspect of the
interaction is usually missed in standard assays that only study
2 time points (immediately after invasion incubation and 2/4
days). In this context, the killing and intracellular replication rates
may also influence the final outcome of the interaction of MAP
and MDMs. Statistical analysis of each process (e.g., killing and
replication-stabilization phases) depicted in these curves was per-
formed. Results indicated that strains 4H2 (P < 0.05) and 40A9
(P < 0.05) were killed much more rapidly than K-10, while 22F4
(P < 0.001) showed an unexpected increase in CFUs during the
first 6 h. The intracellular replication rates (evaluated between 12
and 48 h) were similar for the wild type and all mutant strains,
except for 3H4 (P < 0.01) and 40A9 (P < 0.001) that grew faster
than K-10.
Figure 10 displays CFU burdens at Day 0 after invasion incu-
bation (striped bars) and Day 2 (solid bars) for mutant and wild
type strains. As the MAP inoculums for MDMs were approxi-
mately the same for all strains, the CFU burdens at Day 0 are
proportional to strain invasiveness (Figure 8). Thus, direct com-
parisons of Day 0 CFU burdens yielded similar P values for
pair-wise comparisons as those observed for differences in inva-
sion, except that the decrease in invasiveness for 3H4 (P < 0.001)
vs. K-10 had a greater significance level. Nonetheless, the analysis
based on percent invasion presented in Figure 8 is more accu-
rate, as any differences in the inoculums are taken into account.
Regarding strain intracellular survival, as indicated by the CFU
burdens for each strain at Day 0 and Day 2, no significant
FIGURE 9 | Survival and replication of MAP wild type K-10 and mutant
strains in bovine macrophages. Procedures followed are described in
Lamont and Sreevatsan (2010). Kinetics of MAP intracellular survival and
replication (after invasion) are based on the following formula:
% Survival = (CFU/mltime,t/CFU/mltime,t=0) × 100%; time, t is any of the
time points while time, t = 0 is the time point immediately after completion
of invasion incubation. Results represent means (n = 3) ± standard error of
the mean. See text for relevant P-values.
differences were observed for strains 30H9, 40A9, and STM68
(P > 0.1). For K-10, the decrease observed in survival is moder-
ate, but falls within statistical significance (P < 0.05). In contrast,
marked decreases are observed for 2E11 (P < 0.001) and 4H2
(P < 0.01). Interestingly, 3H4 (P < 0.001) and 22F4 (P < 0.001)
were able to survive and replicate significantly better than K-
10 intracellularly. Comparisons of the overall macrophage CFU
burdens at Day 2 among all strains allow us to determine the com-
bined effects of invasion and intracellular survival/replication.
The results indicate that strain 2E11 is definitively attenuated in
comparison to K-10 (P < 0.001); while 4H2 is slightly attenuated,
but this difference is not statistically significant. Strains 22F4,
40A9, and STM68 behaved similarly to K-10 (P > 0.1), while
strains 3H4 (P < 0.05) and 30H9 (P < 0.05) seem to reach higher
CFU burdens than K-10.
In summary for the interaction of MAP strains with MDMs,
mutants 2E11, 3H4, and 22F4 were less invasive than K-10. In
relation to survival, 2E11 and 4H2 displayed marked reductions.
For the overall Day 2 CFU burdens, only 2E11 was attenuated.
Overall, strains 22F4, 40A9, and STM68 behaved similarly to K-
10, while 3H4 and 30H9 reached a higher number of intracellular
bacilli. For the killing phase, 4H2 and 40A9 were killed faster
than K-10 and all mutant strains were able to grow intracellu-
larly at approximately the same rate, except for 3H4 and 40A9
that replicated faster.
Complementation analysis
We also attempted to develop a complementation system for the
Tn5367 transposon mutants using a derivative of the multi-copy
plasmid pMV206_Hyg (George et al., 1995). To this end, vec-
tor pBUN277 was constructed carrying a hyg marker and the
green fluorescent protein gene downstream from the mycobac-
terial heat shock promoter hsp60. Assessment of wild type K-10,
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FIGURE 10 | MAP burdens of wild type K-10 and mutant strains in
bovine macrophages. Procedures followed are described in Lamont and
Sreevatsan (2010). Total CFU burdens at Day 0 (2 h after infection, striped
bars) and Day 2 (solid bars) are displayed. Results represent means
(n = 3) ± standard error of the mean. Statistical significance for pairwise
determinations displayed by a line with tick marks is denoted with
asterisks: ∗P-value < 0.05, ∗∗P-value < 0.01 and ∗∗∗P-value < 0.001.
4H2 and the empty vector control 4H2 (pBUN277) in MDMs
yielded anomalous results. The survival of 4H2 was significantly
different (P < 0.05) from K-10 at 5 days post-infection, while
the survival of 4H2 (pBUN277) was not significantly different
(P > 0.05) from K-10 (unpublished results). In addition, the sur-
vival of 4H2 recombinant strains carrying either the wild type
gene MAP1152 or MAP1156 yielded similar results to the empty
vector control (P > 0.05). This data indicates that the comple-
mentation system developed was not appropriate and further
attempts were no longer pursued for additional mutants.
DISCUSSION
The objective of our study was to generate a comprehensive MAP
mutant bank and isolate strains with interesting phenotypic prop-
erties and identify genomic regions associated with virulence
that could be targeted for further development of live-attenuated
vaccine strains. Mutants identified for at least one phenotypic
property potentially related to virulence are displayed in Table S1.
This set of 123 strains represents ca. 1% of the mutant bank. The
uniqueness of our approach was to perform the screen indepen-
dently of homology searches for genes already identified in related
mycobacterial species, so as to maximize hits in genes specific
for MAP.
Statistical considerations, coupled with the demonstration
that randomly picked mutants were independent, suggest that
the library was comprehensive: e.g., mutants displayed unique
hybridization bands to the IS1096 probe (see Section Southern
hybridization) and diverse phenotypes (Table S1). It is especially
noteworthy that five of the mutants selected for the vaccine trail
(3H4, 4H2, 22F4, 30H9, and 40A9) and three additional mutants
identified as attenuated in BoMac cells or preliminary MDM
assays (12G8, 23B5, and 37D1) were all associated with altered
DCS susceptibility. As for the rapid screens for cell association,
and biofilm and clump formation, five (1B11, 3D9, 4E1, 4E7,
and 4F3) out of ca. 300 screened mutants (approximately 1.5%)
of the pool, identified strains with properties that may relate
to virulence, but did not overlap with the DCS altered sus-
ceptibility set. Thus, implementation of additional screens, or
expansion of the screens reported herein may still reveal a sig-
nificant number of potentially attenuated mutants. However, the
inherent bias of IS1096-derived transposons limits somewhat the
comprehensiveness of the mutant bank (McAdam et al., 2002;
Shin et al., 2006). Fortunately, Himar-derived transposons with
more random recognition sequences have been developed for
mycobacteria (Sassetti and Rubin, 2003) and are already in use
for MAP (Scandurra et al., 2009; Wang et al., 2014). These vec-
tors may provide a more representative mutant repertoire, but at
the cost of a significant increase (ca. 10-fold) in the number of
mutants that should be screened for a comprehensive analyses.
In addition, best recommended screening approaches for Himar
libraries are focused on gene identification analyses under spec-
ified selection pressures (Sassetti and Rubin, 2003). Individual
deletion mutants and complementation analysis must then be
performed to further confirm the role of these genes in virulence.
Thus, the library described herein is useful as source of individual
mutants for identification of genes involved inMAP pathogenesis,
but implementation of additional screens to formally determine
its comprehensiveness may not be warranted. Nonetheless, as
described, we performed three comprehensive screens (colony
morphology, DCS hypersusceptibility and siderophore produc-
tion), and three additional limited screens for reduced biofilm
and clump formation, and decreased cell association with BoMac
cells. Assuming thatmost of these insertions are in different genes,
this collection may represent insertions in ca. 120 genes. In this
context, previous studies with MTB demonstrated that 194 genes
are required for infection in mice (Sassetti and Rubin, 2003).
Seven Tn5367 mutants from the set depicted in Table S1 as
well as STM68, amutant from the Tn5370 signature-taggedmuta-
genesis pool, were further characterized and their properties are
summarized in Table 2. In our comprehensive screening of the
mutant bank using a chromogenic assay for siderophore detec-
tion, only mutant 1F3 did not display a halo in the CAS plate
assay. This mutant grew very slowly in broth cultures but was
able to colonize goats (Livneh et al., 2005). Unfortunately, as
indicated above, stocks in two laboratories failed to grow upon
further attempts at replication and the transposon insertion site
could not be determined. The CAS assay phenotype has been
associated with impairment of siderophore synthesis or secre-
tion in Msmeg (Fiss et al., 1994). Thus, the properties of 1F3
suggests that MAP has at least an additional siderophore-like
molecule that may be involved in iron uptake and play impor-
tant physiologic roles. Though MAP has a truncated mbtA gene
that most likely underlies its inability to synthesize mycobactin
(Li et al., 2005), mycobactin-dependence is observed mainly in
MAP cultured directly from primary lesions or other clinical spec-
imens. In passaged cultures, mycobactin dependence can be read-
ily overcome in acidic iron-rich media (Lambrecht and Collins,
1992). Thus, we hypothesized that 1F3 may have had a lesion
in a gene encoding for a siderophore-like molecule other than
mycobactin.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2014 | Volume 4 | Article 144 | 11
Rathnaiah et al. Mycobacterium paratuberculosis mutant bank
Table 2 | Screening and characterization of MAP strains.
Straina ORF(s)—Mutated or Affectedb ORFs Functionc Original Screen and Further Commentsd
1F3 Tn5367 insertion was not identified Not applicable Chromogenic screen for siderophore synthesis or
transport; mutant lost upon subsequent passages
2E11
Vaccine
316
Tn5367 between
MAP3695 (Rv0245) and FadE5
(Rv0244c)
MAP3695 (hypothetical protein)
FadE5 (terpenoid and polyketide metabolism)
Attenuated in MDMs for invasion and intracellular
survival
3H4
Vaccine
320
Tn5367 between MAP2296c
(Rv2478c) and MAP2297c (Rv0102)
MAP2296c and MAP2297c (hypothetical
proteins)
DCS hypersusceptible mutant chosen as control
for normal colony morphology.
Attenuated for invasion in MDMs, but has faster
intracellular replication
4H2
Vaccine
321
Tn5367 between MAP1150c
(Rv3640c) and MAP1151c (Rv2839c)
Upstream from MAP1152
(Rv1808)-MAP1156 (Rv1425) cluster
MAP1150c (IS1311 transposase)
MAP1151c (translational initiation factor IF2)
MAP1152 (PPE protein)
MAP1156 (diacyglycerol O-acyltransferase)
Colony-morphology mutant, attenuated for invasion
in BoMac cells, and invasion and survival in MDMs.
Mutant also displayed DCS hypersusceptibility.
22F4
Vaccine
317
Tn5367 within
MAP0460 (Rv3597c, Lsr2)
Lsr2 (H-NS like iron-regulated DNA binding
protein that also provides protection against
oxidative stress)
DCS hypersusceptible; attenuated for survival in
BoMac cells and invasion in MDMs
30H9
Vaccine
319
Tn5367 within
MAP1566 (Rv1645c) near 5′-end
coding sequence
MAP1566
ORF downstream from ModA (MAP1565) in
the mod operon
DCS hypersusceptible; attenuated for invasion in
BoMac cells
40A9
Vaccine
318
Tn5367 between MAP0282c
(Rv3860) and MAP0283c (Rv2082)
MAP0282c and MAP0283c (hypothetical
proteins, assigned with low confidence); or
spontaneous rRNA mutations
Decreased susceptibility to DCS; transposon lost
upon further passage; attenuated in MDMs by
increased killing rate
STM68
Vaccine
315
Tn5370 within
MAP1566 (Rv1645c) near 3′-end
coding sequence
MAP1566
ORF downstream from ModA (MAP1565) in
the mod operon
Identified as MAP1566 insertion by direct
sequencing of Tn5370 signature-tagged
mutagenesis pool
aLaboratory designation followed by the vaccine trial designation (Bannantine et al., 2014; Hines et al., 2014).
bMAP ORF designation is followed by MTB definite or putative ortholog in parenthesis.
cSee text for citations on ORFs functions as applicable.
d See text for further details.
Mutant 2E11 was a false positive for reduced biofilm forma-
tion, but it was nonetheless selected for further studies, since
preliminary assays indicated attenuation in MDMs. Assignment
of the target gene for mutant 2E11 was not fully resolved
in this study as the Tn5367 insertion was mapped to the
intergenic region (Figure 5) encoding an acyl-coA dehydroge-
nase (MAP3694c, aka FadE5) and a possible oxidoreductase
(MAP3695). Interestingly, FadE5 is involved in lipid degrada-
tion (http://www.ncbi.nlm.nih.gov/biosystems/1743) including
the metabolism of terpenoids and polyketides, such as geran-
iol, and these compound types have been associated with biofilm
formation in bacteria (Zheng et al., 2013). MAP FadE5 is orthol-
ogous to MTB Rv0244c, which has been shown to be required
for in vitro growth on cholesterol (http://tuberculist.epfl.ch). This
mutant was the most attenuated in this study on account of both
invasiveness and survival in MDMs.
Mutant 3H4 displayed a transposon insertion in the inter-
genic region between MAP2296c and MAP2297c. Both these
ORFs encode for hypothetical proteins, with the MTB ortholog
(Rv2478c) possibly encoding a non-essential DNA binding
protein, and MAP2297c ortholog (Rv0102) identified as an inte-
gral essential membrane protein and ABC transporter that may
underlie the DCS hypersusceptible phenotype (http://tuberculist.
epfl.ch). Though, this mutant was originally selected as a nor-
mal colony morphotype control, it displayed hypersusceptibility
to DCS. Nonetheless, this strain behaved similarly to the wild
type K-10 strain in both BoMac cells and MDMs, except that
it displayed an attenuated invasion phenotype in the interaction
with MDMs that was compensated with a higher intracellular
replication rate.
In 4H2, the transposon inserted within the intergenic region
between MAP1150c and MAP1151c. MAP1150c is the trans-
posase for IS1311 (Murcia et al., 2007), an insertion sequence
present at eight copies in the MAP genome (Li et al., 2005). Thus,
any effect of this insertion on the MAP1150c is not likely to have
a major impact on MAP physiology. In addition, the insertion
may not have an effect on MAP1151c either as the transposon is
located beyond the 3′-end of this coding sequence. However, there
is a gene cluster (MAP1152-MAP1156) (Bannantine et al., 2011)
that is transcribed from the complementary strand toMAP1150c,
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whose expression could be effected by the transposon insertion
that is located 634 bp upstream from the 5′-end of MAP1152.
This gene cluster is very interesting since MAP1152, MAP1153
and MAP 1155 encode PPE proteins of the ancestral sublineage
IV (Gey Van Pittius et al., 2006). PPE proteins have been sug-
gested to play a role as host range determinants (Cole et al.,
1998) and the immunopathogenesis of both humoral and cel-
lular responses in MTB (Choudhary et al., 2003; Okkels et al.,
2003) andMAP (Nagata et al., 2005). Other PPE proteins in MTB
(Rv1807, Rv3872, and Rv3873) have been implicated in virulence
since inactivation of the corresponding genes results in mutants
attenuated in mice (Sassetti and Rubin, 2003). In addition, PPE
and PE proteins function in pairwise combinations of interact-
ing partners exposed to the cell surface (Riley et al., 2008) and
both sets are markedly underrepresented in MAP (cf. 36 PPE
proteins in MAP vs. 68 in MTB) (Li et al., 2005). The other
members of the gene cluster, MAP1154 and MAP1156, encode
proteins of an uncharacterized protein family. MAP1154 encodes
a hypothetical protein, while MAP1156 has putative diacyglycerol
O-acyltransferase activity (Bannantine et al., 2011). Mutant 4H2
was clearly attenuated in both BoMac andMDM cells, on account
of reduced invasiveness and intracellular survival. Moreover,
we have demonstrated that MAP1152 and MAP1156 engender
humoral immunity responses that can be used to identify infected
animals and thus, the corresponding mutants have potential for
DIVA (differentiating infected from vaccinated animals) vaccine
formulations (Bannantine et al., 2011).
Mutants 22F4 and 30H9 were identified as DCS hypersuscep-
tible strains. Isolate 22F4 carries an insertion within the gene
encoding the Lsr2 protein that has been implicated in various
roles: dominant T cell responses in MTB (Stewart et al., 2002)
and biofilm formation and colony morphology in Msmeg (Chen
et al., 2006). Furthermore, a MAP lsr2 deletion mutant has been
constructed (Park et al., 2008) that showed similar properties
and a marginal degree of attenuation in MDMs to 22F4 (Lamont
et al., 2014), thus providing strong evidence that the transpo-
son insertion, that is internal to lsr2, does disrupt the function
of this gene.
Strain 30H9 has an insertion internal to MAP1566 and prox-
imal to its 5′-end coding sequence. Likewise, STM68 carries an
insertion in MAP1566 but closer to its 3′-end that could poten-
tially have a greater effect on the downstream gene MAP1567.
The cluster MAP1565-MAP1568 seems to comprise an operon
encoding a high affinity molybdate transport system, as indi-
cated by bioinformatic analysis (Braibant et al., 2000). Orthologs
are present in M. avium strain 104 (MAV_2862, 99% identity),
MTB (Rv1645c, 35% identity, 50% similarity) as well as other
mycobacterial species. However, only the MAP and M. avium
104 strain orthologs are located within the Mod operon, mak-
ing this arrangement unique to these species. We hypothesize
that MAP1566 could be a chaperone that works in concert with
this transport system, while MAP1565 (ModA) and MAP1567
(ModB) are integral membrane proteins that constitute and sta-
bilize the transport channel. It seems that MAP1569 (ModD) has
a function in fibronectin binding unrelated to this molybdenum
transport system (Kumar et al., 2003) and thus it may corre-
spond to a different transcriptional unit. Strong evidence for the
transposon insertions affecting the functions ofMod operon (e.g.,
MAP1566 or MAP1567) is provided by the similar properties of
both mutants in MDMs, mice (Bannantine et al., 2014) and goats
(Hines et al., 2014). These mutants were attenuated in C57BL/6
mice but protective against wild type challenge, displayed low skin
reactivity in goats and showed significant attenuation in MDM
assays as analyzed elsewhere (Lamont et al., 2014). However, in
this current analysis, 30H9 and STM68 were comparable to the
wild type strain. Interestingly, another MAP1566 Tn5367 mutant
(WAg906), derived from theMAPwild type strain 989 (Cavaignac
et al., 2000), was shown to be attenuated based on the aver-
age slope values obtained in long-term MDM assays as well as
BALB/c mice at 12 weeks post-infection (Scandurra et al., 2010;
Bannantine et al., 2014; Lamont et al., 2014). However, in pro-
tection challenge experiments, 30H9 and STM68 showed good
protection in C57BL/6 mice against wild type challenge, while
WAg906 failed to protect BALB/c mice. Use of different MAP and
mouse strains may explain these results. These threemutants were
attenuated for survival in goats, but only 30H9 and STM68 were
tested for protection against challenge, displaying low efficacy
(Scandurra et al., 2010; Hines et al., 2014).
As for 40A9, the loss of the transposon insertion does not
allow us tomake any definitive conclusions on themolecular basis
underlying its attenuation. However, this mutant still retained
the Kan-resistant phenotype suggesting the involvement of spon-
taneous mutations in ribosomal RNA genes (Du et al., 2013).
Nonetheless, this mutant was the most protective from this col-
lection in the goat trial (Hines et al., 2014). The most interesting
property observed for this strain was a fast intracellular killing in
MDMs followed by its ability to recover and grow (Figure 9), but
otherwise this strain reached a similar CFU burden as K-10 at Day
2 post-infection (Figure 10).
Regarding the complementation studies, there are several rea-
sons that may explain the anomalous results including: (i) the
hyg marker may increase the survival of the host strains as it
was observed for Msmeg recombinant strains (Chacon et al.,
2009); (ii) the inherent instability of the Tn5367 mutant strains
with the potential for further transposition events by a cut
and paste mechanism (McAdam et al., 1995); (iii) the pos-
sibility of spurious recombination events for strains carrying
multiple copies of wild type DNA sequences in the comple-
menting plasmids and the transposon interrupted copies in the
genome. Due to these difficulties, conclusions regarding the
roles of the genes identified in this study are still presumptive
rather than definitive. Nonetheless, the bioinformatic analysis
and the correlation with our previous results and those from
other laboratories increase the confidence that most of these
genes are relevant to MAP survival and pathogenesis. Moreover,
MAP slow growth and low transformation efficiency place an
onerous time demand on further attempts to revisit comple-
mentation studies (Foley-Thomas et al., 1995). These issues
may underlie the lack of reported complementation analysis in
previous MAP transposon mutant reports (Shin et al., 2006;
Scandurra et al., 2009, 2010). To overcome these complications,
we are currently implementing more solid strategies to con-
struct and complement deletion mutants using different selection
markers.
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An important objective of this study was to compare the inter-
action of different MAP strains with BoMac cells and MDMs in
this study and the parallel study in the vaccine trial (Lamont et al.,
2014). In our studies, the order of attenuation in BoMac cells
and MDM cultures (comparing invasion percentiles and slopes
for each infection phase) was significantly different. Strain 30H9
displayed the greatest attenuation in BoMac cells, while it was the
least attenuated in theMDM assays based on the analysis reported
herein. Mutants 3H4 and 22F4 yielded less discrepancy, while
4H2 behaved similarly. However, when the strains were com-
pared only by the average slope values in MDM assays (Lamont
et al., 2014), results were closer to those obtained with BoMac
cells, with 30H9 yielding the greatest attenuation among the four
strains that were also tested in BoMac cells. Notably, 3H4, 22F4,
and 30H9 had major differences in invasiveness for the two cell
types: 3H4 and 22F4 were invasive for BoMac cells, but not for
MDMs (Figures 3, 8), while the opposite was observed for 30H9.
The differences observed are likely due to the inherent nature of
the BoMac cell line that has poor phagocytosis and decreased abil-
ity to sustain intracellular MAP replication, as shown previously
for the wild type strain K-10 (Woo et al., 2006). A similar situation
seems to occur in MDM aging cultures (Scandurra et al., 2010;
Lamont et al., 2014). Thus, determination of the early kinetics at
each phase (e.g., invasion, intracellular killing and replication), as
done in this study, seems to provide the best assessment of strain
attenuation for studies in ruminants. This analysis may be supple-
mented with assays to determine apoptosis andmeasure cytokines
such as IL-10 (Scandurra et al., 2010; Kabara and Coussens, 2012;
Lamont et al., 2014).
Comparing the results from this study with the recent vac-
cine trial, though not conclusive, sheds some light on the relation
among the various models and vaccine protection for ruminants.
Attenuation in BoMac cells and analysis of average slopes in
MDM assays showed significant correlation with attenuation and
protection in C57BL/6 mice vaccinated by intraperitoneal injec-
tion, but not with orally vaccinated goats (Bannantine et al., 2014;
Hines et al., 2014; Lamont et al., 2014). In contrast, the analysis in
this manuscript of MDM assays correlated well with protection
results in goats. Indeed, the four strains tested in goats ranked
similarly; except for the inversion between 2E11 (most attenuated
in MDMs as reported here, but ranked 2nd in goats) and 40A9
(ranked 2nd in MDMs, but most protective in goats).
As to the MAP mutant properties necessary to elicit protec-
tive immunity in ruminants, based on the conditions tested in
the vaccine trial, interplay between attenuation and virulence
seems necessary. Moreover, a level of persistence (e.g., able to
colonize well in vivo at early time points but lead to significant
reduction in colonization at later times post-infection) has been
hypothesized as one desirable property for the design of MTB live
attenuated vaccines (Hingley-Wilson et al., 2003). For example,
40A9 would be considered rather wild type like, based on the
CFU burdens at either Day 0 or Day 2 (Figure 10). However,
this strain displays both faster killing and intracellular replica-
tion rates (Figure 9). Significant killing of 40A9 in their first
encounter with macrophages may provide sufficient attenuation
while preserving protective immunogenicity. The subsequent fast
intracellular recovery may lead to a persistent behavior. Though,
40A9 was not tested in BALB/c mice for the persistent phenotype,
this behavior was observed for Vaccine 329 that outperformed
40A9 in goats (Shin et al., 2006; Hines et al., 2014). In con-
trast, 30H9 and STM68 displayed a behavior similar to the wild
type K-10 in each of the steps involved in the interaction of the
mutant strains with MDMs (Figures 8–10), but performed worse
in the goat vaccination trial. In addition, little correlation was
observed between the mouse and goat trails, though in this case
the more susceptible C57BL/6 mice were used (Bannantine et al.,
2014). Thus, the level of protection of a candidate vaccine strain
may depend on earlier interactions of the mutant strains with
the oral, gastric and intestinal mucosa, and intracellular killing
and replication rates in MDMs (Bermudez et al., 2010). In addi-
tion, there still remains significant issues regarding tissue culture
(BoMac vs. MDM cells), analysis of tissue culture results, ani-
mal model (BALB/c and C57BL/6 mice or goats), dose (low vs.
high) and routes of inoculation (intraperitoneal, oral and subcu-
taneous) that need further testing and standardization to make
better predictions on protection for JD vaccines in cattle.
CONCLUSIONS
The major accomplishments and findings of this study are: (1) a
comprehensive MAP Tn5367 transposon mutant bank was con-
structed by indexing a large collection of independent mutants
that was statistically representative of the full genome; (2) Tn5367
mutants were inherently unstable due to the IS1096 transposase
presence within the transposed sequence; (3) phenotypic screens
were effective in identifying attenuated mutants or processes of
importance for pathogenesis or cell physiology: (a) the presence
of additional siderophores other than mycobactin (e.g., 1F3), (b)
the association of colony morphotypes with reduced virulence
(e.g., 4H2 and 22F4), (c) the association of drug-susceptible (e.g.,
22F4 and 30H9) or resistant (e.g., 4H2 and 40A9) phenotypes
with reduced virulence and (d) the potential role of cell asso-
ciation, and biofilm and clump formation with virulence (see
SectionMiscellaneous screening); (4) mutant screening in BoMac
cells and MDMs yields significantly different results; (5) strain
invasiveness and slope values at each step in the interaction of
MAP bacilli with MDMs, especially the slopes during the early
killing phase, are the best predictors for protection against wild
type challenge in the oral goat vaccination model; (6) the inter-
action of MAP with MDMs is complex and key aspects of this
process involve: invasion, intracellular killing, intracellular repli-
cation andmaintenance of CFU intracellular burdens; (7) mutant
screening with BoMac cells may have significant biases and it
should be abandoned as a routine methodology to assess attenu-
ation; and (8) the most important stages of MAP interaction with
MDMs in tissue culture occur at relatively short times (up to 48 h
post-invasion incubation). Our results suggests that further stud-
ies with MAP mutants should focus on early step-wise analysis of
their interactions with MDMs and the use of transposon delivery
vectors that lack the transposase within the transposed element
(e.g., Tn5370 and the newly developed Himar1 derivatives).
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Figure S1 | (A–D) Screening of MAP mutants for susceptibility or
resistance to DCS. All mutants were plated on MOADC-Plus media
without (A,C) and with (B,D) DCS at 20μg/ml and allowed to grow for 8
weeks. There are two different scale bars displayed since a Fisherbrand
08-757-14 round (A,C) or Corning 431110 square (B,D) plate was utilized.
Mutants with altered DCS susceptibility are circled with black outlines: the
rough colony morphotype 4H2 (A,B) displays a resistant phenotype while
the smooth colony morphotype 22F4 (C,D) displays hypersusceptibility.
Figure S2 | Rapid screening for MAP mutants with decreased biofilm
formation. The left image depicts a MAP mutant with reduced biofilm
formation while the image on the right is a mutant with normal biofilm
formation.
Figure S3 | (A,B) Rapid screening for MAP mutants with reduced cell
association. A rapid in vitro assay was developed to screen the library for
mutants with decreased cell association (e.g., less adherence and/or
invasion) with BoMac cells. Cells were plated on a 16-well chamber slide
and infected with MAP wild type and mutant strains. At 24 h
post-incubation, slides were fixed and acid-fast bacteria were stained by
the Auramine-Rhodamine method that yields green fluorescence for
acid-fast bacilli. Representative microscopic images from an infection with
the wild type strain K-10 (A) and a mutant with decreased cell association
(B) are shown. Internal scale bar is 100μm.
Figure S4 | (A,B) Rapid screening for MAP mutants with reduced clump
formation. To test for mutants with reduced clump formation, a property
that could be related to virulence, broth cultures were analyzed by
microscopy. Microscopic images of the wild type strain K-10 (A) and a
mutant with reduced clump formation (B) are shown. Internal scale bar
is 10μm.
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